semaglutide controversies Lately, Ozempic and Wegovy have gotten plenty of media attention—and are sparking controversy over who should be taking these medications. For some, taking means dealing with side effects that can Navigating the Controversies of Semaglutide:

Sweating is not listed as a common adverse effect in the official prescribing information for most GLP-1 receptor agonists, and there is no established direct pharmacological mechanism linking these medications to increased perspiration

Dave explains why the answer may have nothing to do with the drug itself, and everything to do with the patient experience

Your body, especially your brain, relies on a steady supply of glucose for energy

We also found low Glp-1r mRNA expression in heart, which supports recent findings on the role of GLP-1R in atrial function [11]

These statements have not been evaluated by the Food and Drug Administration